WeVote

Bill

Bill

S 3000

Order relative to authorizing the joint committee on State Administration and Regulatory Oversight to make an investigation and study of a certain current Senate document relative to sell naming rights to the Boston Convention and Exhibition Center and other properties operated by the MCCA.

193rd Legislature (2023-2024)

Massachusetts legislature authorizes investigation of selling naming rights to Boston Convention Center and MCCA properties to generate public facility revenue.

Order reported favorably by committee and referred to the committee on Rules of the two branches, acting concurrently
0
WeVote Research Nonpartisan
Bill Summary · S 3000

Legislative bill overview

S 3000 authorizes a joint legislative committee to investigate and study the proposal to sell naming rights to the Boston Convention and Exhibition Center and other Massachusetts Convention Center Authority (MCCA) properties. This is an investigative order that does not itself enact policy but rather directs a committee to examine the feasibility, terms, and implications of such a naming rights agreement.

Why is this important

Naming rights deals can generate significant revenue for public facilities—potentially millions annually—but also involve trade-offs regarding public asset control, corporate branding of public spaces, and accountability. The investigation will inform whether Massachusetts should pursue this revenue strategy and under what conditions, affecting both the state's budget and the public's relationship with these major civic venues.

Potential points of contention

  • Public asset commercialization: Whether selling naming rights to public facilities inappropriately commodifies civic infrastructure or is a pragmatic revenue solution
  • Transparency and public input: Concerns about whether a naming rights deal would be adequately vetted through public democratic processes before implementation
  • Financial terms: Questions about what price is adequate compensation and whether the state would secure competitive bidding or favorable long-term renewal terms

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.